Equity Details
Price & Market Data
Price: $3.65
Daily Change: -$0.15 / 4.11%
Daily Range: $3.65 - $3.86
Market Cap: $34,905,372
Daily Volume: 34,245
Performance Metrics
1 Week: 1.07%
1 Month: -5.99%
3 Months: -26.08%
6 Months: -45.52%
1 Year: -58.57%
YTD: -52.28%
About CervoMed Inc. (CRVO)
Get current market data for CervoMed Inc. (CRVO). Price: 3.65, daily change: -$0.15 / 4.11%. Market cap: 34,905,372. Performance YTD, 1-week, 3-month.
Company Details
Employees: 15
Sector: Commercial services
Industry: Miscellaneous commercial services
Country: United States
Details
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.